Pioglitazone Therapy Targeting Fatigue in Breast Cancer
Latest Information Update: 14 Jul 2022
Price :
$35 *
At a glance
- Drugs Pioglitazone (Primary)
- Indications Muscle fatigue
- Focus Pharmacodynamics; Pharmacogenomic
- 11 Jul 2022 Planned End Date changed from 1 Apr 2022 to 1 Apr 2023.
- 11 Jul 2022 Planned primary completion date changed from 1 Apr 2022 to 1 Apr 2023.
- 23 Dec 2021 New trial record